Biotech Wisperer - Search Videos

Including results for biotech whisperer.

Do you want results only for Biotech Wisperer?

DARPA's BUDGET: Since 9/11, US biodefense has quietly crossed $100 billion. The office running point on biotech was founded in 2014 — the same year Ukraine was imploding."4.3 billion 2026, 5 billion requested for 2027.""How about 2014? Just so happened when Ukraine was imploding.""Programs include pandemic prevention platform... or adept EDP. That's nucleic acid vaccines contributing to the MRNA technology."But remember this is just "biodefense" and "biological research." @teamfroglogic

DARPA's BUDGET: Since 9/11, US biodefense has quietly crossed $100 billion. The office running point on biotech was founded in 2014 — the same year Ukraine was imploding."4.3 billion 2026, 5 billion requested for 2027.""How about 2014? Just so happened when Ukraine was imploding.""Programs include pandemic prevention platform... or adept EDP. That's nucleic acid vaccines contributing to the MRNA technology."But remember this is just "biodefense" and "biological research." @teamfroglogic

3.9K views2 weeks ago

x.comThe David Rutherford Show

NEW: Biotech executive was found dead after being thrown from a 25th-floor balcony in Miami BeachAuthorities say Justin Zelin, 35, died from blunt force trauma after falling from his apartment on the 25th floorJust three days earlier, surveillance video captured Zelin entering the building with Corey Hutterli, 37, who was carrying several bottles of alcoholPolice say Zelin had called 911 moments before the fall to report a disturbanceWhen officers arrived, they found Hutterli leaving the apartme

NEW: Biotech executive was found dead after being thrown from a 25th-floor balcony in Miami BeachAuthorities say Justin Zelin, 35, died from blunt force trauma after falling from his apartment on the 25th floorJust three days earlier, surveillance video captured Zelin entering the building with Corey Hutterli, 37, who was carrying several bottles of alcoholPolice say Zelin had called 911 moments before the fall to report a disturbanceWhen officers arrived, they found Hutterli leaving the apartme

24.3K views4 weeks ago

x.comUnlimited L's

The next setup is hiding in a biotech stock that's been flat for years.Here's why:- The business is growing while the stock is flat- Institutions are likely to accumulate during the dead zone- A near-term event like earnings, an FDA approval, or a spinoff is approaching that hasn't been priced in.When all three line up, the stock hasn't caught up to the business yet. ADPT fits all three signs. I'd suggest putting it on your watch list and wait.

The next setup is hiding in a biotech stock that's been flat for years.Here's why:- The business is growing while the stock is flat- Institutions are likely to accumulate during the dead zone- A near-term event like earnings, an FDA approval, or a spinoff is approaching that hasn't been priced in.When all three line up, the stock hasn't caught up to the business yet. ADPT fits all three signs. I'd suggest putting it on your watch list and wait.

36.6K views1 week ago

x.comFelix Prehn 🐶

Dario Amodei thinks biotech is about to have a renaissance driven by AI

Dario Amodei thinks biotech is about to have a renaissance driven by AI

11.5K views1 month ago

x.comHealthcare AI Guy

𝟏𝟎𝐱 𝐆𝐞𝐧𝐨𝐦𝐢𝐜𝐬: At the 2026 @humancellatlas General Meeting in Boston, @10xGenomics is showing researchers its newest tool, Atera, which sets a new standard for single cell spatial biology.Full video: https://t.co/KsDRdnL8pP

𝟏𝟎𝐱 𝐆𝐞𝐧𝐨𝐦𝐢𝐜𝐬: At the 2026 @humancellatlas General Meeting in Boston, @10xGenomics is showing researchers its newest tool, Atera, which sets a new standard for single cell spatial biology.Full video: https://t.co/KsDRdnL8pP

2.3K views2 weeks ago

if you believe in scientific superintelligence in the life-sciences, and you also believe that china ascendency to biotech is worrying, *and* you also believe that the outsourcing of wet-lab work will continue: ‘cloud labs becoming a reality’ is one of the easiest logical conclusionsof course, the exact shape that a cloud lab takes is a bit less predictable. do they go all in on intelligence, and spread to every corner of wet-lab biology? or do they stay focused, building beachheads, establishin

if you believe in scientific superintelligence in the life-sciences, and you also believe that china ascendency to biotech is worrying, *and* you also believe that the outsourcing of wet-lab work will continue: ‘cloud labs becoming a reality’ is one of the easiest logical conclusionsof course, the exact shape that a cloud lab takes is a bit less predictable. do they go all in on intelligence, and spread to every corner of wet-lab biology? or do they stay focused, building beachheads, establishin

17.7K views1 month ago

🇨🇳 💉 💊 The recent, sudden rise of Chinese biotechnology dominance has caused many to propose protectionist policies against China to protect the U.S. While I understand those motives, there may be a better way. Last week, I spoke at CTS about how:-FDA can make it much easier & quicker & cheaper to do trials in the United States -Offer incentives (including quicker review times) for drugs manufactured and tested in the U.S. Obviously, it’s much more complicated than this, but we must consider

🇨🇳 💉 💊 The recent, sudden rise of Chinese biotechnology dominance has caused many to propose protectionist policies against China to protect the U.S. While I understand those motives, there may be a better way. Last week, I spoke at CTS about how:-FDA can make it much easier & quicker & cheaper to do trials in the United States -Offer incentives (including quicker review times) for drugs manufactured and tested in the U.S. Obviously, it’s much more complicated than this, but we must consider

13.2K views1 week ago

x.comHouman David Hemmati, MD, PhD

𝐅𝐫𝐨𝐦 𝐋𝐨𝐧𝐝𝐨𝐧: At @NucleateUK's The Forum in London, former @novonordisk CSO Marcus Schindler reflects on the success of the GLPs and shares advice for biotech entrepreneurs in Europe.Full video: https://t.co/O0BuUaL5R6

2.9K views3 weeks ago

It’s well known that we we are in the middle of the 4th Industrial Revolution (transhumanism) which merges human biology with technology. What do you think the terms biotechnology or synthetic biology mean? (Copyright Karen Kingston)

39.3K views3 weeks ago

x.comKaren Kingston

How do we scale biotech while safeguarding against biological risk?We asked American Wetware CEO @p_maverick_b:"As we get better at engineering biology, we should also get better at biosecurity.""Better AI models like AlphaFold mean it's more predictive, 'I am pretty sure this protein binds the receptor I'm trying to drug.' That's a big step forward.""As the models get better at reasoning and learning the why of what they're trying to do, that improved reasoning also helps biosecurity.""A very s

2.8K views4 weeks ago

#InnoSparkBytes — विज्ञान Tech 2026 | In-House Innovation Spotlight SeriesAt विज्ञान Tech 2026, Dr. Divakar Hemadri from @icarindia- NIIVEDI, shares insights on innovative biotechnology solutions that are advancing healthcare and strengthening India's scientific ecosystem.The showcased innovation highlights the role of research-driven technologies in addressing real-world challenges through a collaborative "Whole-of-Government" approach. By translating scientific discoveries into impactful appli

182 views1 week ago

x.comDepartment of Biotechnology

𝐅𝐫𝐨𝐦 𝐍𝐘𝐒𝐄: @AstraZeneca's CEO Pascal Soriot shares his take on M&A, oncology, Baxfendy for hypertension, the obesity market, and more. $AZNFull video: https://t.co/kZIVYJLWD7

8K views3 weeks ago

Sai Life Sciences CFO Siva Chittor says growth remains largely pharma-led, with biotech contributing on the CRO side. He expects steady demand momentum, with FY27 starting on a strong note.Watch the full conversation on #KnowYourCompany with @Sharad9Dubey. @SaiLifeSciences

3.4K views3 weeks ago

x.comNDTV Profit

This interview of Jake Van Naarden $LLY head of corporate business development, by @angelicapeebles - CNBC’s excellent Pharma reporter, has demonstrated once again just how far-sighted Eli Lilly’s strategy really is and how it helps Eli Lilly to strengthen its dominance in the BioTech and Pharma ecosystem. I was especially interested to learn more about the rationale behind Eli Lilly’s staggering deal-making pace and that there is much more to come M&A-wise. Definitely worth your time! $XBI

16.4K views4 weeks ago

x.comYair Einhorn

#InnoSpark Bytes — विज्ञान Tech 2026 | In-House Innovation Spotlight SeriesDr. Sonali Srivastava from @NImmunology, New Delhi introduces a sustainable platform technology that directly converts low-cost glucose into high-value delta-lactones.These essential chemical compounds provide vital buttery, creamy, and coconut flavor notes widely used in the food, beverage, and cosmetic industries. By engineering bacteria to achieve an impressive yield of 3.4 g/L nearly three times higher than existing b

334 views3 weeks ago

x.comDepartment of Biotechnology

𝐄𝐇𝐀 𝟐𝟎𝟐𝟔: @CaribouBio's CEO Rachel Haurwitz shares an #EHA2026 update on her company's CD19 and BCMA allogeneic CAR-T programs. $CRBUFull video: https://t.co/CfZYB0he03

1.1K views2 weeks ago

just look at the timeline chadMidjourney just pivoted into medical hardwarea full body scanner that uses sound waves and a pool of water to map your entire body in 60 seconds. no radiation. no MRI tube. no $1,000s billcould you imagine, an image generation company built this before most hospitals modernized their imagingthat should tell you everything about what the future of medicine looks liketurns out the companies with AI infrastructure and capital are now better positioned to build healthca

11.3M views2 weeks ago

x.comMgoes (bio/acc 🤖💉)

Happy $SPCX IPO day to all those that celebrate. And a reminder while everyone's watching: all signs point to $LPTH being a key supplier of optical intersatellite link components for SpaceX Starlink/Starshield. https://t.co/EPHz0g6ojQ

34.7K views2 weeks ago

x.comBussin Science Investor

See more